<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04732728</url>
  </required_header>
  <id_info>
    <org_study_id>92557593</org_study_id>
    <nct_id>NCT04732728</nct_id>
  </id_info>
  <brief_title>LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study</brief_title>
  <acronym>LUX-Dx PERFORM</acronym>
  <official_title>LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LUX-Dx PERFORM Study will characterize, in a general patient population, the utilization&#xD;
      of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor&#xD;
      (ICM) device. The study will also collect data to characterize the performance of arrhythmia&#xD;
      detection algorithms. Finally, data collected will be used to analyze and characterize the&#xD;
      ICM system-related safety events.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2021</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Characterize the utilization of the LUX-Dx remote programming feature</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterize the performance of the LUX-Dx arrhythmia detection algorithms</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ICM System-related Complication-free Rate at 30 days post-implant</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ICM System-related Complication-free Rate at 12 months post-implant</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Syncope</condition>
  <condition>Cryptogenic Stroke</condition>
  <arm_group>
    <arm_group_label>Safety Cohort</arm_group_label>
    <description>No intervention will be administered to subjects that comprise the safety cohort.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Holter Cohort</arm_group_label>
    <description>No intervention will be administered to subjects that comprise the safety cohort.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that have a known heart condition and are at risk of developing an abnormal heart&#xD;
        rhythm, or have symptoms that may suggest a cardiac arrhythmia such as dizziness,&#xD;
        palpitations, syncope, chest pain, and/or shortness of breath.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is indicated to be implanted with the LUX-Dx ICM for one of the following&#xD;
             reasons (grouped in three &quot;Reason for Monitoring&quot; subgroups): 1) Cryptogenic stroke,&#xD;
             2) Syncope, 3) AF management, Post-AF ablation, or Suspected AF&#xD;
&#xD;
          -  Patient is willing to enroll and be monitored in LATITUDE Clarity.&#xD;
&#xD;
          -  Patient is willing and able to be followed remotely via the ICM patient mobile app.&#xD;
&#xD;
          -  Patient is willing and capable of providing informed consent (which is not to include&#xD;
             the use of a legally authorized representative (LAR) for documentation of informed&#xD;
             consent) and agrees to participate in all protocol required activities.&#xD;
&#xD;
          -  Patient is age 18 years or above, or of legal age to give informed consent specific to&#xD;
             state and national law.&#xD;
&#xD;
        The following inclusion criterion is applicable for patients participating in the Holter&#xD;
        study:&#xD;
&#xD;
        â€¢ Patient can tolerate the adhesive used in the Holter monitoring for an extended period of&#xD;
        time.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is indicated for implantation of, or is currently implanted with an active&#xD;
             implantable cardiac device (e.g., LVAD, ICD, CRT D, PPM*).&#xD;
&#xD;
          -  Patient cannot tolerate a subcutaneous, chronically-inserted device due to medical&#xD;
             condition.&#xD;
&#xD;
          -  Patient has a documented life expectancy of less than 12 months (per investigator's&#xD;
             discretion).&#xD;
&#xD;
          -  Patient is known to be pregnant at the time of study enrollment (method of assessment&#xD;
             upon investigator's discretion).&#xD;
&#xD;
          -  Patient is currently enrolled in another clinical study including observational&#xD;
             studies/registries, unless prior written approval from BSC is obtained. Mandatory&#xD;
             governmental registries are accepted for co-enrollment without approval by BSC.&#xD;
&#xD;
        The following exclusion criteria are applicable for patients participating in the Holter&#xD;
        study:&#xD;
&#xD;
          -  Patient has known allergies to the adhesive materials or hydrogel used in the extended&#xD;
             Holter monitoring.&#xD;
&#xD;
          -  Patient has broken, damaged, or irritated skin over the chest area where the extended&#xD;
             Holter monitor will be attached.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas Stoltz</last_name>
    <phone>651-582-4912</phone>
    <email>thomas.stoltz@bsci.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heart Center Research, LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Jennings, MD</last_name>
    </contact>
    <investigator>
      <last_name>John Jennings, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arrythmia Research Group</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devi Nair, MD</last_name>
    </contact>
    <investigator>
      <last_name>Devi Nair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Medical Group</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Dukes, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jonathan Dukes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiac Arrhythmia Service</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33432</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Rosman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jonathan Rosman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Venkata Bavikati, MD</last_name>
    </contact>
    <investigator>
      <last_name>Venkata Bavikati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Idaho Cardiology Associates</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Marks, MD</last_name>
    </contact>
    <investigator>
      <last_name>Melinda Marks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denice Hodgson-Zingman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Denice Hodgson-Zingman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas City Arrhythmia Research LLC</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Koerber, DO</last_name>
    </contact>
    <investigator>
      <last_name>Scott Koerber, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cox Health</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Garner, MD</last_name>
    </contact>
    <investigator>
      <last_name>John Garner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Firas Hamdan, MD</last_name>
    </contact>
    <investigator>
      <last_name>Firas Hamdan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bethesda North Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaurang Gandhi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gaurang Gandhi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Richards, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mark Richards, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian University of Pennsylvania Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Bullinga, MD</last_name>
    </contact>
    <investigator>
      <last_name>John Bullinga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Monument Health Rapid City Hospital</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ethan Levine, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ethan Levine,, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erlanger Medical Center</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harish Manyam, MD</last_name>
    </contact>
    <investigator>
      <last_name>Harish Manyam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amin Al-Ahmad, MD</last_name>
    </contact>
    <investigator>
      <last_name>Amin Al-Ahmad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olusegun Olusesi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olusegun Olusesi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Southwest Medical</name>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <zip>98664</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John MacGregor, MD</last_name>
    </contact>
    <investigator>
      <last_name>John MacGregor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 27, 2021</study_first_submitted>
  <study_first_submitted_qc>January 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

